Skip to main content
Genmab A/S (LON:0MGB)
London flag London · Delayed Price · Currency is GBP · Price in DKK
1,587.50
+47.50 (3.08%)
At close: Feb 20, 2025

Genmab Revenue

In the year 2024, Genmab had annual revenue of 21.53B DKK with 30.67% growth. Genmab had revenue of 6.44B in the quarter ending December 31, 2024, with 35.34% growth.

Revenue
21.53B DKK
Revenue Growth
+30.67%
P/S Ratio
n/a
Revenue / Employee
8.03M DKK
Employees
2,682
Market Cap
11.15B GBP

Revenue Chart

* This company reports financials in DKK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202421.53B5.05B30.67%
Dec 31, 202316.47B1.97B13.57%
Dec 31, 202214.51B6.09B72.33%
Dec 31, 20218.42B-1.69B-16.75%
Dec 31, 202010.11B4.75B88.43%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.19B
Shell 227.10B
HSBC Holdings 48.93B
Unilever 50.25B
Rio Tinto Group 42.86B
RELX PLC 9.43B
BP p.l.c. 149.68B
British American Tobacco p.l.c. 25.87B
Revenue Rankings

Genmab News

More News